Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-14 @ 3:08 AM
Study NCT ID:
NCT02787304
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2016-05-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)
Sponsor:
Mirum Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-11
First Submit QC Date:
None
Study First Post Date:
2016-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-28
Results First Submit QC Date:
None
Results First Post Date:
2019-11-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL